1. Home
  2. NEWT vs PROC Comparison

NEWT vs PROC Comparison

Compare NEWT & PROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEWT
  • PROC
  • Stock Information
  • Founded
  • NEWT N/A
  • PROC 1976
  • Country
  • NEWT United States
  • PROC Luxembourg
  • Employees
  • NEWT N/A
  • PROC N/A
  • Industry
  • NEWT Major Banks
  • PROC Biotechnology: Pharmaceutical Preparations
  • Sector
  • NEWT Finance
  • PROC Health Care
  • Exchange
  • NEWT Nasdaq
  • PROC Nasdaq
  • Market Cap
  • NEWT 338.4M
  • PROC 283.2M
  • IPO Year
  • NEWT N/A
  • PROC N/A
  • Fundamental
  • Price
  • NEWT $14.38
  • PROC $2.42
  • Analyst Decision
  • NEWT Buy
  • PROC Hold
  • Analyst Count
  • NEWT 4
  • PROC 1
  • Target Price
  • NEWT $14.50
  • PROC $4.50
  • AVG Volume (30 Days)
  • NEWT 163.5K
  • PROC 3.6K
  • Earning Date
  • NEWT 08-05-2024
  • PROC 09-03-2024
  • Dividend Yield
  • NEWT 5.29%
  • PROC N/A
  • EPS Growth
  • NEWT 7.14
  • PROC N/A
  • EPS
  • NEWT 1.80
  • PROC 0.52
  • Revenue
  • NEWT $199,910,000.00
  • PROC $414,096,000.00
  • Revenue This Year
  • NEWT $34.20
  • PROC $5.54
  • Revenue Next Year
  • NEWT $6.03
  • PROC $8.54
  • P/E Ratio
  • NEWT $7.99
  • PROC $4.62
  • Revenue Growth
  • NEWT 59.31
  • PROC N/A
  • 52 Week Low
  • NEWT $10.07
  • PROC $1.95
  • 52 Week High
  • NEWT $19.36
  • PROC $4.95
  • Technical
  • Relative Strength Index (RSI)
  • NEWT 63.99
  • PROC 39.63
  • Support Level
  • NEWT $12.40
  • PROC $2.49
  • Resistance Level
  • NEWT $15.22
  • PROC $2.81
  • Average True Range (ATR)
  • NEWT 0.41
  • PROC 0.09
  • MACD
  • NEWT 0.20
  • PROC -0.00
  • Stochastic Oscillator
  • NEWT 70.63
  • PROC 4.87

About NEWT NewtekOne Inc.

NewtekOne Inc is a financial holding company engaged in providing financial solutions, It has developed a financial and technology-based business model that enables itself to acquire and process its clients in a very cost-effective manner. This capability is supported in large part by NewTracker, its patented prospect management technology software, that will allow NewtekOne clients to easily interact with NewtekOne subject matter experts in the areas of Banking, Lending, Payments, Technology, Payroll, and Insurance. It offers NewtekOne's clients a single online dashboard to access all of NewtekOne's business and financial solutions. It has four reportable segments Banking, Technology, NSBF, and Payments.

About PROC Procaps Group S.A.

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Share on Social Networks: